Halozyme Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Okay. I think it's about 10:40, so why don't we get started with the next session? By introduction, my name is Graig Suvannavejh. I'm on the biotech research team here at Goldman Sachs. But before I introduce our next guest and speaker, there are some disclaimers that I am obligated to read, so please bear with me.
We are required to make certain disclosures and public appearances about Goldman Sachs' relationships with companies that are being discussed. Disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available on our most recent reports available to U.S. clients on our firm's portal.
Lastly, the views stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.
So with that, I want to welcome Halozyme CEO, Helen Torley. Welcome. And in the audience, we also have Vice
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
